Biomics Biopharma (ASX:BBM) Other Current Payables: A$0.00 Mil (As of . 20)


What is Biomics Biopharma Other Current Payables?

Biomics Biopharma ASX:BBM Other Current Payables is A$0.00 Mil as of . 20.

Biomics Biopharma's Other Current Payables for the quarter that ended in . 20 was A$0.00 Mil.

Biomics Biopharma Other Current Payables Related Terms

Biomics Biopharma Other Current Payables Historical Data

* Premium members only.

The historical data trend for Biomics Biopharma's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomics Biopharma Other Current Payables Chart

Biomics Biopharma Annual Data
Trend
Other Current Payables

Biomics Biopharma Semi-Annual Data
Other Current Payables

Biomics Biopharma Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of A$0.00 Mil mean?
Biomics Biopharma (ASX:BBM) has a Other Current Payables of A$0.00 Mil as of . 20. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Biomics Biopharma and its competitors.
Is Biomics Biopharma's Other Current Payables too high?
Biomics Biopharma's current Other Current Payables is A$0.00 Mil.
How does Biomics Biopharma's Other Current Payables compare to competitors?
Biomics Biopharma's Other Current Payables of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Biomics Biopharma and its competitors. Biomics Biopharma's current Other Current Payables is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomics Biopharma stock overvalued right now?
Biomics Biopharma (ASX:BBM) has a current Other Current Payables of A$0.00 Mil. The current Other Current Payables is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Biomics Biopharma (ASX:BBM), the current Other Current Payables is A$0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biomics Biopharma Business Description

Address 1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.